Regional abnormality of grey matter in schizophrenia: Effect from the illness or treatment?

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Yue, Ying ^a   Kong, Li ^b,c   Wang, Jijun ^c,d   Li, Chunbo ^c,d   Tan, Ling ^d   Su, Hui ^c,d   Xu, Yifeng ^c,d  

^a Mental Health Centre of Huangpu District   (China)

^b SHANGHAI NORMAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; OLANZAPINE; QUETIAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN SIZE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; INSULA; LEFT HEMISPHERE; LONGITUDINAL STUDY; MALE; MORPHOMETRICS; NEGATIVE SYNDROME; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PREFRONTAL CORTEX; RIGHT HEMISPHERE; SCHIZOPHRENIA; SUPERIOR OCCIPITAL CORTEX; SUPERIOR TEMPORAL GYRUS; TENSOR BASED MORPHOMETRY; THALAMUS; VOXEL BASED MORPHOMETRY; BRAIN MAPPING; CASE CONTROL STUDY; COMPARATIVE STUDY; DRUG EFFECTS; IMAGE PROCESSING; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN MAPPING; CASE-CONTROL STUDIES; FEMALE; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84958581606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147204     Document Type: Article

References (47)

1. Honea R, Crow TJ, Passingham D, Mackay CE Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry. 2005; 162: 2233-2245. PMID: 16330585
2. Shenton ME, Dickey CC, Frumin M, McCarleyRW A review of MRI findings in schizophrenia. Schizophr Res. 2001; 49: 1-52.
3. Shenton ME, Whitford TJ, Kubicki M Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci. 2010; 12: 317-332. PMID: 20954428
4. Narayanaswamy JC, Kalmady SV, Venkatasubramanian G, Gangadhar BN Clinical correlates of superior temporal gyrus volume abnormalities in antipsychotic-naive schizophrenia. J Neuropsychiatry Clin Neurosci. 2015; 27: e128-133. doi: 10.1176/appi.neuropsych.14030049 PMID: 25923856
5. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC Subcortical MRI volumes in neurolepticnaive and treated patients with schizophrenia. Am J Psychiatry. 1998; 155: 1711-1717. PMID: 9842780
6. Ichimiya T, Okubo Y, Suhara T, Sudo Y Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia. Biol Psychiatry. 2001; 49: 20-27. PMID: 11163776
7. Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, et al. Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? J Psychiatr Res. 1998; 32: 161-167. PMID: 9793869
8. Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology. 2005; 30: 765-774. PMID: 15702141
9. Deng MY, McAlonan GM, Cheung C, Chiu CP, Law CW, Cheung V, et al. A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naive, newly diagnosed schizophrenia. Psychopharmacology (Berl). 2009; 206: 437-446.
10. Lehman AF, Steinwachs DM Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998; 24: 1-10. PMID: 9502542
11. Kay SR, Fiszbein A, Opler LA The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13: 261-276. PMID: 3616518
12. Ashburner J, Friston KJ Voxel-based morphometry - the methods. Neuroimage. 2000; 11: 805-821. PMID: 10860804
13. Good CD, Johnsrude I, Ashburner J, Henson RN, Friston KJ, Frackowiak RS Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage. 2001; 14: 685-700. PMID: 11506541
14. Kipps CM, Duggins AJ, Mahant N, Gomes L, Ashburner J, McCusker EA Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J Neurol Neurosurg Psychiatry. 2005; 76: 650-655. PMID: 15834021
15. Kong L, Bachmann S, Thomann PA, Essig M, Schroder J Neurological soft signs and gray matter changes: a longitudinal analysis in first-episode schizophrenia. Schizophr Res. 2012; 134: 27-32. doi: 10.1016/j.schres.2011.09.015 PMID: 22018942
16. Whitford TJ, Grieve SM, Farrow TF, Gomes L, Brennan J, Harris AW, et al. Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage. 2006; 32: 511-519. PMID: 16677830
17. Guo X, Li J, Wang J, Fan X, Hu M, Shen Y, et al. Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia. Schizophr Res. 2014; 152: 339-343. doi: 10.1016/j.schres.2013.12.015 PMID: 24439000
18. Zheng LR, Wang YX, Li M, Li LJ, Kang Z, Guo XF, et al. [A study of cerebral cortex in untreated first-episode schizophrenics]. Zhonghua Yi Xue Za Zhi. 2013; 93: 3252-3255. PMID: 24401616
19. Chan RC, Di X, McAlonan GM, Gong QY Brain anatomical abnormalities in high-risk individuals, firstepisode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr Bull. 2011; 37: 177-188. doi: 10.1093/schbul/sbp073 PMID: 19633214
20. Kong L, Herold CJ, Zollner F, Salat DH, Lasser MM, Schmid LA, et al. Comparison of grey matter volume and thickness for analysing cortical changes in chronic schizophrenia: a matter of surface area, grey/white matter intensity contrast, and curvature. Psychiatry Res. 2015; 231: 176-183. doi: 10.1016/j.pscychresns.2014.12.004 PMID: 25595222
21. Belin P, Zatorre RJ, Lafaille P, Ahad P, Pike B Voice-selective areas in human auditory cortex. Nature. 2000; 403: 309-312. PMID: 10659849
22. Wright TM, Pelphrey KA, Allison T, McKeown MJ, McCarthy G Polysensory interactions along lateral temporal regions evoked by audiovisual speech. Cereb Cortex. 2003; 13: 1034-1043. PMID: 12967920
23. Scherk H, Falkai P Effects of antipsychotics on brain structure. Curr Opin Psychiatry. 2006; 19: 145-150. PMID: 16612194
24. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry. 2005; 62: 361-370. PMID: 15809403
25. Miller DD, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry. 2001; 49: 704-715. PMID: 11313038
26. Strungas S, Christensen JD, Holcomb JM, Garver DLState-related thalamic changes during antipsychotic treatment in schizophrenia: preliminary observations. Psychiatry Res. 2003; 124: 121-124. PMID: 14561430
27. Crosson B, Hughes CW Role of the thalamus in language: is it related to schizophrenic thought disorder? Schizophr Bull. 1987; 13: 605-621. PMID: 3326161
28. Andreasen NCThe role of the thalamus in schizophrenia. Can J Psychiatry. 1997; 42: 27-33. PMID: 9040920
29. Byne W, Hazlett EA, Buchsbaum MS, Kemether E The thalamus and schizophrenia: current status of research. Acta Neuropathol. 2009; 117: 347-368. doi: 10.1007/s00401-008-0404-0 PMID: 18604544
30. Cohen BM, Wan W, Froimowitz MP, Ennulat DJ, Cherkerzian S, Konieczna H Activation of midline thalamic nuclei by antipsychotic drugs. Psychopharmacology (Berl). 1998; 135: 37-43.
31. Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, et al. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS). Pharmacopsychiatry. 2005; 38: 214-219. PMID: 16189748
32. Goghari VM, Smith GN, Honer WG, Kopala LC, Thornton AE, Su W, et al. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naive first-episode psychosis patients. Schizophr Res. 2013; 149: 149-155. PMID: 23830856
33. Garver DL, Holcomb JA, Christensen JD Cerebral cortical gray expansion associated with two secondgeneration antipsychotics. Biol Psychiatry. 2005; 58: 62-66. PMID: 15992524
34. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry. 2008; 165: 1015-1023. doi: 10.1176/appi.ajp.2008.07101562 PMID: 18381902
35. Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry. 2003; 60: 878-888. PMID: 12963669
36. Nakamura M, Salisbury DF, Hirayasu Y, Bouix S, Pohl KM, Yoshida T, et al. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry. 2007; 62: 773-783. PMID: 17586477
37. Narr KL, Bilder RM, Toga AW, Woods RP, Rex DE, Szeszko PR, et al. Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex. 2005; 15: 708-719. PMID: 15371291
38. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2001; 58: 148-157. PMID: 11177116
39. Horacek J, Bubenikova-Valesova V, Kopecek M, Palenicek T, Dockery C, Mohr P, et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs. 2006; 20: 389-409. PMID: 16696579
40. Wylie KP, Tregellas JR The role of the insula in schizophrenia. Schizophr Res. 2010; 123: 93-104. doi: 10.1016/j.schres.2010.08.027 PMID: 20832997
41. Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry. 1999; 56: 537-547. PMID: 10359468
42. Kim JJ, Mohamed S, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, et al. Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography. Am J Psychiatry. 2000; 157: 542-548. PMID: 10739412
43. Crespo-Facorro B, Kim J, Andreasen NC, O'Leary DS, Bockholt HJ, Magnotta V Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophr Res. 2000; 46: 35-43. PMID: 11099884
44. Pressler M, Nopoulos P, Ho BC, Andreasen NC Insular cortex abnormalities in schizophrenia: Relationship to symptoms and typical neuroleptic exposure. Biol Psychiatry. 2005; 57: 394-398. PMID: 15705355
45. Yeganeh-Doost P, Gruber O, Falkai P, Schmitt A The role of the cerebellum in schizophrenia: from cognition to molecular pathways. Clinics (Sao Paulo). 2011; 66 Suppl 1: 71-77.
46. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry. 1999; 46: 908-920. PMID: 10509174
47. Malla AK, Bodnar M, Joober R, Lepage M Duration of untreated psychosis is associated with orbitalfrontal grey matter volume reductions in first episode psychosis. Schizophr Res. 2011; 125: 13-20. doi: 10.1016/j.schres.2010.09.021 PMID: 21059482